Page last updated: 2024-08-17

mannitol and Cystic Fibrosis of Pancreas

mannitol has been researched along with Cystic Fibrosis of Pancreas in 88 studies

Research

Studies (88)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (3.41)	18.7374
1990's	6 (6.82)	18.2507
2000's	17 (19.32)	29.6817
2010's	52 (59.09)	24.3611
2020's	10 (11.36)	2.80

Authors

Authors	Studies
Ademhan Tural, D; Dogru, D; Emiralioglu, N; Guzelkas, I; Kiper, N; Nayir Buyuksahin, H; Ozcelik, U; Ozsezen, B; Sunman, B; Yalçın, E	1
Duman, I; Durduran, Y; Güney, AY; Pekcan, S; Ünal, G; Yilmaz, AI	1
Bar-Yoseph, R; Bentur, L; Gur, M; Hakim, F; Hanna, M; Laghi, L; Levanon, S; Marazzato, M; Masarweh, K; Wilschanski, M; Zuckerman-Levin, N	1
McDonald, VM; Smith, S; Wark, P	1
Cavallaro, G; Di Leonardo, A; Giammona, G; Lentini, L; Porsio, B; Quaglia, F; Ungaro, F	1
Dwyer, T; Murray, CS; Nevitt, SJ; Thornton, J	2
Bem, RA; Linssen, RSN; Ma, J; Rubin, BK	1
Aitken, ML; Amelina, E; Charlton, B; Daines, CL; Flume, PA; Guasconi, A; Leadbetter, J	1
Montgomery, M; Yang, C	2
Hupp, S; Luckett, P; Papacostas, MF	1
Anderson, SD; Brannan, JD; Chan, HK; Daviskas, E	1
Bacle, A; Becq, F; Cantereau, A; Ferreira, T; Ferru-Clément, R; Hélye, R; Jayle, C; Kadri, L; Payet, LA; Vandebrouck, C	1
Leadbetter, J; Morgan, K; Schwenkglenks, M; Toward, TJ; Warren, E	1
Clancy, JP; Ranganathan, S; Southern, KW	1
Doull, I	1
Amaral, MD; Cardoso, SR; de Carvalho, RB; Kunzelmann, K; Meirelles, LR; Ribeiro, AF; Ribeiro, JD; Ribeiro, MA; Servidoni, MF; Sousa, M; Vinagre, AM	1
Donaldson, SH; Galietta, L	1
Ong, T; Ramsey, BW	1
Adler, AI; George, E; Jennings, G; Jonsson, PF	1
Barraud, N; Buson, A; Jarolimek, W; Rice, SA	1
Steinkamp, G	1
Rademacher, J; Ringshausen, FC; Welte, T	1
Bassinet, L; Chedevergne, F; Delaisi, B; Desmazes-Dufeu, N; Dubus, JC; Reychler, G; Vecellio, L	1
Bilton, D; Stanford, G	1
Barker, AF; Bilton, D; Chambers, DC; Charlton, B; De Soyza, A; Dupont, LJ; Fox, HG; O'Dochartaigh, C; Tino, G; van Haren, EH; Vidal, LO; Welte, T; Wu, J	1
Jaffe, A; McKay, K; Middleton, A; Robinson, PD; Selvadurai, H	1
Rogers, DF; Tildy, BE	1
Grillo, L; Main, E; Rand, S	1
Dwyer, T; Murray, CS; Nolan, SJ; Thornton, J	2
Hebert, WP; Mastoridis, P; O'Toole, GA; Orazi, G; Price, KE; Ruoff, KL	1
Chilvers, M; Montgomery, M; Nolan, SJ; Yang, C	1
Bennett, WD; Donaldson, SH; Henderson, AG	1
Cazzarolli, C; Pradal, U; Tartali, C	1
Cavallaro, G; Craparo, EF; Cusimano, MG; Giammona, G; Porsio, B; Schillaci, D; Spigolon, D	1
Charlton, B; De Boeck, K; Haarman, E; Hull, J; Lands, LC; Leadbetter, J; Malfroot, A; Moeller, A; Munck, A; Riethmüller, J; Tiddens, H; Volpi, S	1
Storey, S; Wald, G	1
Bilton, D	1
Bush, A; Metcalfe, C; Minasian, C; Wallis, C	2
Amin, R; Ratjen, F	1
Bell, SC; Reid, DW	1
Spector, S	1
Dragomir, A; Johannesson, M; Lazorova, L; Nilsson, HE; Roomans, GM	1
Anderson, SD; Charlton, B; Daviskas, E; Jaques, A	1
Donaldson, SH; Paré, PD; Rosenfeld, M; Tiddens, HA	1
Gruenert, DC; Hanrahan, JW; LeSimple, P; Liao, J; Robert, R	1
Adi, H; Agus, H; Chan, HK; Traini, D; Young, PM	1
Boucher, RC; Button, B; Goralski, JL	1
Charlton, B; Jaques, A; Teper, A	1
Davis, SD; Ferkol, TW	1
Bilton, D; Charlton, B; Cooper, P; Fox, H; Gallagher, CG; Jaques, A; Kolbe, J; Robinson, P	1
Lin, Q; Shin, S; Tsifansky, MD; Yang, Y; Yeo, Y	1
Han, B; Ibrahim, BM; Park, S; Yeo, Y	1
Aitken, ML; Bellon, G; Charlton, B; De Boeck, K; Flume, PA; Fox, HG; Geller, DE; Haarman, EG; Hebestreit, HU; Lapey, A; Schou, IM; Zuckerman, JB	1
Bilton, D; Hurt, K	1
Trapnell, BC	1
Burness, CB; Keating, GM	1
Holme, H; Winckworth, LC	1
Aitken, ML; Bellon, G; Bilton, D; Charlton, B; Cooper, P; De Boeck, K; Flume, PA; Fox, HG; Gallagher, CG; Geller, DE; Haarman, EG; Hebestreit, HU; Kolbe, J; Lapey, A; Robinson, P; Wu, J; Zuckerman, JB	1
Daviskas, E; Rubin, BK	1
Brown, AR; Denman, CC	1
al Habasch, O; Baron, O; Despins, P; Duveau, D; Fabre, S; Haloun, A; Michaud, JL; Treilhaud, M	1
Anderson, SD; Bye, PT; Daviskas, E; Robinson, M	1
Hirsh, AJ	1
Abraham, WM; Boucher, RC; Hirsh, AJ; Hopkins, S; Paradiso, AM; Sabater, JR; Smith, RT; Zamurs, A	1
Baron, EJ; D'Souza, HA	1
Wills, PJ	1
Bush, A; Minasian, CC; Wallis, C	1
Anderson, SD; Bye, PTP; Charlton, B; Cooper, P; Daviskas, E; Jaques, A; LeSouëf, PN; McKay, K; Robertson, CF; Shadbolt, B; Stirling, RG; Turton, JA	1
Boucher, RC; Clunes, MT	1
Calayag, C; Matsumoto-Pon, J; Ohrui, T; Skach, W; Thompson, M; Widdicombe, JH	1
Austin, S; Green, MR; Jolliffe, S; McClean, P; Weaver, LT	1
Austin, S; Green, MR; Weaver, LT	1
Heymans, HS; Mulder, CJ; Uil, JJ; van Aalderen, WM; van Elburg, RM	1
Anderson, SD; Baker, J; Bye, PT; Chan, HK; Daviskas, E; Eberl, S; Robinson, M	1
Guggino, WB	1
Forget, PP; Hendriks, HJ; van Kreel, B	1
Khubchandani, KR; Oberley, RE; Snyder, JM	1
Billington, D; Dalzell, AM; Freestone, NS; Heaf, DP	1
Brunetto, A; Eastham, EJ; Laker, MF; Murphy, MS; Nelson, R; Pearson, AD; Sheldon, W	1
Baxter, PS; Hardcastle, J; Hardcastle, PT; Read, NW; Taylor, CJ; Wilson, AJ	1
Ingelfinger, JR; Klahr, S; Robson, AM; Strominger, DB; Tateishi, S	1

Reviews

32 review(s) available for mannitol and Cystic Fibrosis of Pancreas

Article	Year
Nebulised hypertonic saline for cystic fibrosis. The Cochrane database of systematic reviews, 2023, 06-14, Volume: 6 Topics: Administration, Inhalation; Adolescent; Adult; Amiloride; Child; Child, Preschool; Cystic Fibrosis; Humans; Infant; Mannitol; Middle Aged; Saline Solution, Hypertonic; Sodium; Xylitol; Young Adult	2023
Inhaled mannitol for cystic fibrosis. The Cochrane database of systematic reviews, 2020, 05-01, Volume: 5 Topics: Administration, Inhalation; Adult; Child; Cystic Fibrosis; Deoxyribonuclease I; Forced Expiratory Volume; Humans; Mannitol; Mucociliary Clearance; Powders; Randomized Controlled Trials as Topic; Recombinant Proteins; Respiratory Function Tests; Vital Capacity	2020
Rational use of mucoactive medications to treat pediatric airway disease. Paediatric respiratory reviews, 2020, Volume: 36 Topics: Adolescent; Adrenal Cortex Hormones; Asthma; Bronchiectasis; Bronchiolitis, Viral; Child; Child, Preschool; Cholinergic Antagonists; Ciliary Motility Disorders; Cystic Fibrosis; Deoxyribonuclease I; Diuretics, Osmotic; Epithelial Sodium Channel Blockers; Expectorants; Humans; Infant; Macrolides; Mannitol; Recombinant Proteins; Respiratory System Agents; Saline Solution, Hypertonic; Severity of Illness Index	2020
Dornase alfa for cystic fibrosis. The Cochrane database of systematic reviews, 2021, 03-18, Volume: 3 Topics: Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Deoxyribonuclease I; Disease Progression; Expectorants; Forced Expiratory Volume; Humans; Infant; Mannitol; Placebos; Randomized Controlled Trials as Topic; Recombinant Proteins; Saline Solution, Hypertonic; Vital Capacity	2021
The use of pulmonary clearance medications in the acutely ill patient. Expert review of respiratory medicine, 2017, Volume: 11, Issue:10 Topics: Acetylcysteine; Cystic Fibrosis; Deoxyribonuclease I; Expectorants; Heparin; Humans; Lung; Mannitol; Mucociliary Clearance; Recombinant Proteins; Saline Solution, Hypertonic; Smoke Inhalation Injury	2017
Inhaled mannitol for cystic fibrosis. The Cochrane database of systematic reviews, 2018, 02-09, Volume: 2 Topics: Administration, Inhalation; Adult; Child; Cystic Fibrosis; Deoxyribonuclease I; Humans; Mannitol; Mucociliary Clearance; Powders; Randomized Controlled Trials as Topic; Recombinant Proteins; Respiratory Function Tests	2018
Repurposing excipients as active inhalation agents: The mannitol story. Advanced drug delivery reviews, 2018, Volume: 133 Topics: Administration, Inhalation; Asthma; Cystic Fibrosis; Drug Repositioning; Humans; Mannitol	2018
Dornase alfa for cystic fibrosis. The Cochrane database of systematic reviews, 2018, 09-06, Volume: 9 Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Deoxyribonuclease I; Expectorants; Forced Expiratory Volume; Humans; Infant; Mannitol; Randomized Controlled Trials as Topic; Recombinant Proteins; Saline Solution, Hypertonic; Vital Capacity	2018
Aerosolized agents for airway clearance in cystic fibrosis. Pediatric pulmonology, 2019, Volume: 54, Issue:6 Topics: Administration, Inhalation; Aerosols; Child, Preschool; Combined Modality Therapy; Cystic Fibrosis; Decision Making, Shared; Deoxyribonuclease I; Diagnostic Tests, Routine; Drug Administration Schedule; Humans; Infant; Mannitol; Medication Adherence; Recombinant Proteins; Respiratory Therapy; Saline Solution, Hypertonic	2019
Cystic fibrosis papers of the year 2012. Paediatric respiratory reviews, 2013, Volume: 14 Suppl 1 Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Humans; Infant; Mannitol; Outcome Assessment, Health Care; Respiratory Function Tests; Saline Solution, Hypertonic; Treatment Outcome	2013
New pulmonary therapies directed at targets other than CFTR. Cold Spring Harbor perspectives in medicine, 2013, Jun-01, Volume: 3, Issue:6 Topics: Anoctamin-1; Bacteriocins; Chloride Channels; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Deoxycytosine Nucleotides; Diuretics, Osmotic; Epithelial Cells; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Humans; Mannitol; Mucociliary Clearance; Neoplasm Proteins; Peptides; Sodium; Uridine	2013
Modifying disease in cystic fibrosis: current and future therapies on the horizon. Current opinion in pulmonary medicine, 2013, Volume: 19, Issue:6 Topics: Aminophenols; Biomarkers; Cell Membrane; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Genetic Markers; Genetic Therapy; Humans; Male; Mannitol; Mutation; Phenotype; Quinolones; Respiratory System Agents; Saline Solution, Hypertonic	2013
[Dry powder inhalers in cystic fibrosis]. Pneumologie (Stuttgart, Germany), 2014, Volume: 68, Issue:6 Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Diuretics, Osmotic; Drug Compounding; Dry Powder Inhalers; Humans; Mannitol; Powders; Pseudomonas Infections; Tobramycin	2014
[Inhaled treatments in cystic fibrosis: what's new in 2013?]. Revue des maladies respiratoires, 2014, Volume: 31, Issue:4 Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Contraindications; Cystic Fibrosis; Dry Powder Inhalers; Equipment Design; Expectorants; France; Health Services Accessibility; Humans; Mannitol; Nebulizers and Vaporizers; Powders; Saline Solution, Hypertonic	2014
Inhaled mannitol and cystic fibrosis. Unnecessary bronchial irritation. Prescrire international, 2014, Volume: 23, Issue:148 Topics: Administration, Inhalation; Adult; Bronchial Hyperreactivity; Bronchial Spasm; Bronchoconstriction; Capsules; Cystic Fibrosis; Deoxyribonuclease I; Drug Administration Schedule; Dry Powder Inhalers; Hemoptysis; Humans; Mannitol; Powders; Quality of Life; Recombinant Proteins; Risk Factors; Treatment Outcome	2014
The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care? Current opinion in pulmonary medicine, 2014, Volume: 20, Issue:6 Topics: Administration, Inhalation; Combined Modality Therapy; Cystic Fibrosis; Deoxyribonuclease I; Expectorants; Humans; Mannitol; Mucociliary Clearance; Nebulizers and Vaporizers; Physical Therapy Modalities; Recombinant Proteins; Saline Solution, Hypertonic; Sputum; Treatment Outcome	2014
Therapeutic options for hydrating airway mucus in cystic fibrosis. Pharmacology, 2015, Volume: 95, Issue:3-4 Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mannitol; Mucus; Respiratory System; Saline Solution, Hypertonic	2015
Inhaled mannitol for cystic fibrosis. The Cochrane database of systematic reviews, 2015, Oct-09, Issue:10 Topics: Administration, Inhalation; Adult; Cystic Fibrosis; Deoxyribonuclease I; Humans; Mannitol; Mucociliary Clearance; Powders; Randomized Controlled Trials as Topic; Recombinant Proteins	2015
Inhaled Mannitol (Bronchitol) for Cystic Fibrosis. Paediatric respiratory reviews, 2016, Volume: 18 Topics: Administration, Inhalation; Cystic Fibrosis; Diuretics, Osmotic; Humans; Mannitol; Treatment Outcome	2016
Dornase alfa for cystic fibrosis. The Cochrane database of systematic reviews, 2016, Apr-04, Volume: 4 Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Deoxyribonuclease I; Expectorants; Humans; Infant; Mannitol; Randomized Controlled Trials as Topic; Recombinant Proteins; Saline Solution, Hypertonic	2016
Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic Fibrosis. Annals of the American Thoracic Society, 2016, Volume: 13 Suppl 2 Topics: Administration, Inhalation; Bronchitis, Chronic; Cystic Fibrosis; Diuretics, Osmotic; Epithelial Sodium Channel Blockers; Humans; Mannitol; Mucociliary Clearance; Mucus; Saline Solution, Hypertonic	2016
Cystic fibrosis: a review of pulmonary and nutritional therapies. Advances in pediatrics, 2008, Volume: 55 Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diabetes Mellitus; Diuretics, Osmotic; Expectorants; Genetic Therapy; Humans; Inflammation; Lung; Malnutrition; Mannitol; Neutrophils; Respiratory Tract Infections	2008
Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively? Pediatric pulmonology, 2010, Volume: 45, Issue:2 Topics: Administration, Inhalation; Airway Obstruction; Airway Remodeling; Anti-Inflammatory Agents; Child; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Deoxycytosine Nucleotides; Humans; Infant; Ion Transport; Mannitol; Mucociliary Clearance; Mucus; Neutrophils; Pneumonia, Bacterial; Pulmonary Alveoli; Radiography; Respiratory Mucosa; Sodium Channel Blockers; Uridine; Young Adult	2010
Osmolytes and ion transport modulators: new strategies for airway surface rehydration. Current opinion in pharmacology, 2010, Volume: 10, Issue:3 Topics: Animals; Clinical Trials as Topic; Cystic Fibrosis; Diuretics, Osmotic; Drug Synergism; Humans; Ion Transport; Mannitol; Mucociliary Clearance; Respiratory Mucosa; Saline Solution, Hypertonic	2010
Inhaled mannitol for the treatment of cystic fibrosis. Expert review of respiratory medicine, 2012, Volume: 6, Issue:1 Topics: Administration, Inhalation; Cystic Fibrosis; Expectorants; Humans; Lung; Mannitol; Mucociliary Clearance; Powders; Treatment Outcome	2012
Mannitol dry powder for inhalation: in patients with cystic fibrosis. Drugs, 2012, Jul-09, Volume: 72, Issue:10 Topics: Administration, Inhalation; Cystic Fibrosis; Dry Powder Inhalers; Forced Expiratory Volume; Humans; Mannitol; Molecular Structure; Mucociliary Clearance; Randomized Controlled Trials as Topic; Treatment Outcome	2012
Effect of inhaled dry powder mannitol on mucus and its clearance. Expert review of respiratory medicine, 2013, Volume: 7, Issue:1 Topics: Administration, Inhalation; Bronchiectasis; Cystic Fibrosis; Dry Powder Inhalers; Humans; Mannitol; Mucociliary Clearance; Mucus; Powders; Treatment Outcome	2013
Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction. Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, 2002,Fall, Volume: 15, Issue:3 Topics: Bronchiectasis; Cystic Fibrosis; Diuretics, Osmotic; Humans; Mannitol; Mucociliary Clearance; Saline Solution, Hypertonic	2002
Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents. Advanced drug delivery reviews, 2002, Dec-05, Volume: 54, Issue:11 Topics: Administration, Inhalation; Amiloride; Cystic Fibrosis; Epithelium; Humans; Mannitol; Mucociliary Clearance; Mucus; Osmotic Pressure; Respiratory System; Saline Solution, Hypertonic; Sodium Channel Blockers	2002
Inhaled mannitol in cystic fibrosis. Expert opinion on investigational drugs, 2007, Volume: 16, Issue:7 Topics: Administration, Inhalation; Animals; Bronchiectasis; Clinical Trials as Topic; Cystic Fibrosis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drugs, Investigational; Female; Humans; Male; Mannitol; Mice; Mice, Transgenic; Mucociliary Clearance; Sensitivity and Specificity; Treatment Outcome	2007
Mannitol as a mucolytic in cystic fibrosis. Journal of the Royal Society of Medicine, 2007, Volume: 100 Suppl 47 Topics: Adolescent; Adult; Bronchial Provocation Tests; Child; Cystic Fibrosis; Expectorants; Humans; Mannitol; Middle Aged	2007
Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis. Current opinion in pharmacology, 2008, Volume: 8, Issue:3 Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Deoxycytosine Nucleotides; Humans; Ion Transport; Lung; Mannitol; Peptides, Cyclic; Saline Solution, Hypertonic; Sodium Channel Blockers; Uridine	2008

Trials

13 trial(s) available for mannitol and Cystic Fibrosis of Pancreas

Article	Year
Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021, Volume: 20, Issue:6 Topics: Adult; Cystic Fibrosis; Double-Blind Method; Dry Powder Inhalers; Female; Forced Expiratory Volume; Humans; Male; Mannitol	2021
Inhaled mannitol (Bronchitol) for cystic fibrosis. The Medical letter on drugs and therapeutics, 2021, 05-31, Volume: 63, Issue:1625 Topics: Administration, Inhalation; Adolescent; Child; Cystic Fibrosis; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Mannitol	2021
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Thorax, 2014, Volume: 69, Issue:12 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Forced Expiratory Volume; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Mannitol; Medication Adherence; Middle Aged; Mucociliary Clearance; Quality of Life; Recurrence; Sputum; Treatment Outcome; Young Adult	2014
A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation. The European respiratory journal, 2015, Volume: 45, Issue:2 Topics: Administration, Inhalation; Cystic Fibrosis; Double-Blind Method; Dry Powder Inhalers; Humans; Lung Diseases; Mannitol; Oxygen Consumption; Pilot Projects; Powders; Respiratory Function Tests; Sample Size; Spirometry; Treatment Outcome	2015
Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2017, Volume: 16, Issue:3 Topics: Administration, Inhalation; Adolescent; Child; Cystic Fibrosis; Diuretics, Osmotic; Double-Blind Method; Drug Monitoring; Dry Powder Inhalers; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Mucociliary Clearance; Quality of Life; Sputum; Treatment Outcome	2017
Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis. Chest, 2010, Volume: 137, Issue:4 Topics: Administration, Inhalation; Adult; Child; Cross-Over Studies; Cystic Fibrosis; Double-Blind Method; Elasticity; Forced Expiratory Volume; Humans; Lung; Mannitol; Mucus; Sputum; Vital Capacity	2010
Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial. Thorax, 2010, Volume: 65, Issue:1 Topics: Adolescent; Bronchoconstriction; Child; Cough; Cross-Over Studies; Cystic Fibrosis; Deoxyribonuclease I; Drug Therapy, Combination; Expectorants; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Mucociliary Clearance; Powders; Prospective Studies; Recombinant Proteins	2010
Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2011, Volume: 10, Issue:1 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Bronchial Spasm; Child; Chronic Disease; Cystic Fibrosis; Diuretics, Osmotic; Dose-Response Relationship, Drug; Drug Monitoring; Drug Repositioning; Dry Powder Inhalers; Female; Humans; Lung; Male; Mannitol; Middle Aged; Mucociliary Clearance; Pneumonia; Respiratory Function Tests; Treatment Outcome	2011
Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study. The European respiratory journal, 2011, Volume: 38, Issue:5 Topics: Administration, Inhalation; Adolescent; Child; Cystic Fibrosis; Deoxyribonucleases; Double-Blind Method; Dry Powder Inhalers; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Recombinant Proteins; Vital Capacity	2011
Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study. American journal of respiratory and critical care medicine, 2012, Mar-15, Volume: 185, Issue:6 Topics: Administration, Inhalation; Adolescent; Adult; Child; Cystic Fibrosis; Diuretics, Osmotic; Double-Blind Method; Dry Powder Inhalers; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Mannitol; Middle Aged; Mucociliary Clearance; Powders; Prospective Studies; Time Factors; Treatment Outcome; Young Adult	2012
Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:4 Topics: Administration, Inhalation; Adolescent; Adult; Child; Cystic Fibrosis; Female; Humans; Male; Mannitol; Middle Aged; Young Adult	2013
Inhaled mannitol improves lung function in cystic fibrosis. Chest, 2008, Volume: 133, Issue:6 Topics: Administration, Inhalation; Adolescent; Adult; Child; Confidence Intervals; Cross-Over Studies; Cystic Fibrosis; Diuretics, Osmotic; Double-Blind Method; Female; Humans; Male; Mannitol; Middle Aged; Quality of Life; Respiratory Function Tests; Surveys and Questionnaires; Treatment Outcome	2008
The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. The European respiratory journal, 1999, Volume: 14, Issue:3 Topics: Administration, Inhalation; Adolescent; Adult; Bronchi; Cough; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Middle Aged; Mucociliary Clearance; Mucus; Pilot Projects; Saline Solution, Hypertonic; Treatment Outcome	1999

Other Studies

43 other study(ies) available for mannitol and Cystic Fibrosis of Pancreas

Article	Year
Comparison of inhaled mannitol/dornase alfa combination and daily dornase alfa alone in children with cystic fibrosis. Pediatric pulmonology, 2022, Volume: 57, Issue:1 Topics: Adult; Case-Control Studies; Child; Cystic Fibrosis; Deoxyribonuclease I; Humans; Mannitol; Middle Aged; Recombinant Proteins; Retrospective Studies	2022
Inhaled Dry Powder Mannitol Treatment in Pediatric Patients with Cystic Fibrosis: Evaluation of Clinical Data in a Real-World Setting. Pediatric allergy, immunology, and pulmonology, 2022, Volume: 35, Issue:1 Topics: Administration, Inhalation; Adolescent; Child; Cough; Cystic Fibrosis; Emollients; Humans; Mannitol; Powders; Retrospective Studies	2022
The effect of probiotic administration on metabolomics and glucose metabolism in CF patients. Pediatric pulmonology, 2022, Volume: 57, Issue:10 Topics: Adolescent; Adult; Arabinose; Blood Glucose; Blood Glucose Self-Monitoring; Child; Cysteine; Cystic Fibrosis; Cytokines; Diabetes Mellitus; Dysbiosis; Glucose Intolerance; Glutamine; Humans; Indoles; Insulin Resistance; Lactates; Lactulose; Mannitol; Pilot Projects; Probiotics; Prospective Studies; Quality of Life; Young Adult	2022
Inhalable nano into micro dry powders for ivacaftor delivery: The role of mannitol and cysteamine as mucus-active agents. International journal of pharmaceutics, 2020, May-30, Volume: 582 Topics: Administration, Inhalation; Aminophenols; Animals; Cells, Cultured; Chloride Channel Agonists; Cysteamine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Compounding; Drug Liberation; Expectorants; Mannitol; Mutation; Nanoparticles; Peptides; Powders; Quinolones; Rats, Inbred F344	2020
Modulation of cellular membrane properties as a potential therapeutic strategy to counter lipointoxication in obstructive pulmonary diseases. Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:9 Pt B Topics: Adult; Aged; Bronchi; Cell Line; Cell Membrane; Computer Simulation; Cystic Fibrosis; Epithelial Cells; Fatty Acids; Female; Humans; Male; Mannitol; Middle Aged; Molecular Dynamics Simulation; Oleic Acids; Phospholipids; Primary Cell Culture; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa	2018
Cost Effectiveness of Inhaled Mannitol (Bronchitol PharmacoEconomics, 2019, Volume: 37, Issue:3 Topics: Administration, Inhalation; Adolescent; Adult; Australia; Child; Cost-Benefit Analysis; Cystic Fibrosis; Deoxyribonuclease I; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Recombinant Proteins; Young Adult	2019
Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility. BMC gastroenterology, 2013, May-20, Volume: 13 Topics: Adult; Anesthetics, Intravenous; Biopsy; Blotting, Western; Cathartics; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Fluorescent Antibody Technique; Glycerol; Humans; Mannitol; Mutation; Pain; Patient Satisfaction; Prognosis; Rectum; Sodium Chloride; Surgical Instruments; Surveys and Questionnaires	2013
NICE guidance on inhaled mannitol for treatment of cystic fibrosis. The Lancet. Respiratory medicine, 2013, Volume: 1, Issue:1 Topics: Administration, Inhalation; Cystic Fibrosis; Humans; Mannitol; Practice Guidelines as Topic	2013
Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms. PloS one, 2013, Volume: 8, Issue:12 Topics: Anti-Bacterial Agents; Biofilms; Cystic Fibrosis; Diuretics, Osmotic; Drug Resistance, Bacterial; Humans; Mannitol; Mutation; Pneumonia, Bacterial; Pseudomonas aeruginosa; Tobramycin	2013
[Non-cystic fibrosis bronchiectasis [corrected]]. Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:14 Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Diuretics, Osmotic; Humans; Mannitol; Physical Therapy Modalities; Saline Solution, Hypertonic	2014
A double-edged sword. Prescrire international, 2014, Volume: 23, Issue:148 Topics: Bronchial Hyperreactivity; Bronchial Spasm; Bronchoconstriction; Cystic Fibrosis; Humans; Mannitol	2014
Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis. Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:2 Topics: Bronchiectasis; Cough; Cystic Fibrosis; Deoxyribonuclease I; Humans; Lung; Mannitol; Motor Activity; Mucociliary Clearance; Recombinant Proteins; Respiratory Therapy; Saline Solution, Hypertonic	2015
Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation. PloS one, 2015, Volume: 10, Issue:10 Topics: Biofilms; Cystic Fibrosis; Humans; Lung; Mannitol; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2015
The Advantages of Adding Hyaluronic Acid or Mannitol to Hypertonic Saline Inhalation Treatment in Cystic Fibrosis. Journal of aerosol medicine and pulmonary drug delivery, 2017, Volume: 30, Issue:2 Topics: Administration, Inhalation; Cystic Fibrosis; Humans; Hyaluronic Acid; Mannitol; Saline Solution, Hypertonic; Treatment Outcome	2017
Polyanion-tobramycin nanocomplexes into functional microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. Nanomedicine (London, England), 2017, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Drug Carriers; Drug Liberation; Epithelial Cells; Humans; Mannitol; Mucus; Nanocomposites; Polyelectrolytes; Polymers; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2017
Novel agents in cystic fibrosis. Nature reviews. Drug discovery, 2008, Volume: 7, Issue:7 Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Deoxycytosine Nucleotides; Genetic Therapy; Humans; Mannitol; Natriuretic Agents; Osmolar Concentration; Uridine	2008
What did we learn from the North American Cystic Fibrosis Conference? Journal of the Royal Society of Medicine, 2008, Volume: 101 Suppl 1 Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Chloride Channels; Clinical Trials as Topic; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diuretics, Osmotic; Genetic Therapy; Humans; Ion Transport; Mannitol; Quality of Health Care; Saline Solution, Hypertonic; United States	2008
Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis. Pediatric pulmonology, 2008, Volume: 43, Issue:11 Topics: Administration, Inhalation; Adolescent; Bronchial Provocation Tests; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Humans; Male; Mannitol; Mucociliary Clearance; Powders; Respiratory Function Tests; Surface-Active Agents	2008
Sugar sweet and deadly? Microbiology (Reading, England), 2009, Volume: 155, Issue:Pt 3 Topics: Burkholderia cepacia; Burkholderia Infections; Cystic Fibrosis; Humans; Mannitol; Polysaccharides, Bacterial	2009
Use of mannitol inhalation challenge in assessment of cough. Lung, 2010, Volume: 188 Suppl 1 Topics: Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Capsaicin; Cough; Cystic Fibrosis; Humans; Irritants; Mannitol; Mast Cells; Odorants; Powders; Sensation Disorders	2010
CFTR and tight junctions in cultured bronchial epithelial cells. Experimental and molecular pathology, 2010, Volume: 88, Issue:1 Topics: 1-Methyl-3-isobutylxanthine; Actins; Bronchi; Cell Line; Cell Membrane Permeability; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytoskeleton; Electric Conductivity; Humans; Lanthanum; Mannitol; Respiratory Mucosa; Tight Junctions; Time Factors; Tubulin	2010
Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers. The Journal of physiology, 2010, Apr-15, Volume: 588, Issue:Pt 8 Topics: Bronchi; Cell Line; Cell Membrane Permeability; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Genistein; Green Fluorescent Proteins; Humans; Mannitol; Phosphorylation; Protein Kinase Inhibitors; Temperature; Tight Junctions; Tyrosine	2010
Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Jun-14, Volume: 40, Issue:3 Topics: Administration, Inhalation; Anti-Infective Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Cystic Fibrosis; Drug Combinations; Humans; Mannitol; Microbial Sensitivity Tests; Nebulizers and Vaporizers; Powders; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive; Staphylococcus aureus; Streptococcus pyogenes	2010
Hitting the target: new treatments for cystic fibrosis. American journal of respiratory and critical care medicine, 2010, Dec-15, Volume: 182, Issue:12 Topics: Administration, Inhalation; Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Deoxycytosine Nucleotides; Diuretics, Osmotic; Humans; Infant; Mannitol; Treatment Outcome; Uridine; Young Adult	2010
Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model. Biotechnology and bioengineering, 2011, Volume: 108, Issue:6 Topics: Administration, Inhalation; Anti-Infective Agents; Ciprofloxacin; Cystic Fibrosis; Drug Carriers; Humans; Mannitol; Mucus; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Chloride	2011
A strategy to deliver genes to cystic fibrosis lungs: a battle with environment. Journal of controlled release : official journal of the Controlled Release Society, 2011, Oct-30, Volume: 155, Issue:2 Topics: Administration, Inhalation; Animals; Cross-Linking Reagents; Cystic Fibrosis; DNA; Drug Carriers; Drug Compounding; Gene Transfer Techniques; Hyaluronic Acid; Lung; Mannitol; Mice; Nanoparticles; NIH 3T3 Cells; Particle Size; Polyethyleneimine; Sputum; Transfection	2011
Inhaled dry powder mannitol: a solution for cystic fibrosis. American journal of respiratory and critical care medicine, 2012, Mar-15, Volume: 185, Issue:6 Topics: Cystic Fibrosis; Female; Humans; Male; Mannitol; Mucociliary Clearance	2012
Question 3: Inhaled mannitol improves lung function in patients with cystic fibrosis. Archives of disease in childhood, 2012, Volume: 97, Issue:11 Topics: Administration, Inhalation; Child; Cystic Fibrosis; Humans; Mannitol; Prognosis; Respiratory Function Tests	2012
Mannitol promotes adherence of an outbreak strain of Burkholderia multivorans via an exopolysaccharide-independent mechanism that is associated with upregulation of newly identified fimbrial and afimbrial adhesins. Microbiology (Reading, England), 2013, Volume: 159, Issue:Pt 4 Topics: Adhesins, Bacterial; Animals; Bacterial Adhesion; Burkholderia; Burkholderia Infections; Cystic Fibrosis; Disease Models, Animal; Disease Outbreaks; Fimbriae, Bacterial; Humans; Lepidoptera; Mannitol; Molecular Sequence Data; Sequence Analysis, DNA; Up-Regulation	2013
Retrospective clinical comparison of Celsior solution to modified blood Wallwork solution in lung transplantation for cystic fibrosis. Progress in transplantation (Aliso Viejo, Calif.), 2002, Volume: 12, Issue:3 Topics: Albumins; Chlorides; Cystic Fibrosis; Disaccharides; Electrolytes; Female; Glutamates; Glutathione; Histidine; Humans; Lung; Lung Transplantation; Male; Mannitol; Organ Preservation Solutions; Phosphoprotein Phosphatases; Propionates; Protein Tyrosine Phosphatases; Retrospective Studies	2002
Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease. The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:3 Topics: Absorption; Amiloride; Animals; Bronchi; Cystic Fibrosis; Electrophysiology; Epithelial Cells; Epithelial Sodium Channels; Epithelium; Female; Humans; In Vitro Techniques; Lung Diseases; Mannitol; Microscopy, Confocal; Mucus; Muscle Contraction; Sheep; Sodium; Sodium Channel Blockers; Sodium Channels; Viscosity	2004
BBL CHROMagar Staph aureus is superior to mannitol salt for detection of Staphylococcus aureus in complex mixed infections. American journal of clinical pathology, 2005, Volume: 123, Issue:6 Topics: Agar; Animals; Bacteriological Techniques; Chromogenic Compounds; Cystic Fibrosis; Humans; Mannitol; Reproducibility of Results; Sensitivity and Specificity; Sputum; Staphylococcal Infections; Staphylococcus aureus	2005
Radiotracer studies of cystic fibrosis transmembrane conductance regulator expressed in Xenopus oocytes. The American journal of physiology, 1994, Volume: 266, Issue:6 Pt 1 Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenosine Triphosphate; Animals; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electrolytes; Formates; Mannitol; Membrane Proteins; Oocytes; Radioisotopes; Rubidium; Sulfates; Tetradecanoylphorbol Acetate; Xenopus	1994
Spot urine pancreolauryl test for use in infancy. Archives of disease in childhood, 1995, Volume: 72, Issue:3 Topics: Cystic Fibrosis; Diarrhea; Exocrine Pancreatic Insufficiency; Failure to Thrive; Female; Fluorescein; Fluoresceins; Humans; Infant; Male; Mannitol; Sensitivity and Specificity	1995
Dual marker one day pancreolauryl test. Archives of disease in childhood, 1993, Volume: 68, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Biomarkers; Child; Cystic Fibrosis; Female; Fluorescein; Fluoresceins; Humans; Male; Mannitol; Pancreas; Pancreatic Diseases; Pancreatic Function Tests; Time Factors	1993
Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis. Pediatric research, 1996, Volume: 39, Issue:6 Topics: Adolescent; Adult; Capillary Permeability; Carbohydrates; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Humans; Infant; Intestinal Mucosa; Lactulose; Mannitol; Nutritional Physiological Phenomena; Osmolar Concentration; Pancreatitis	1996
Cystic fibrosis salt/fluid controversy: in the thick of it. Nature medicine, 2001, Volume: 7, Issue:8 Topics: Animals; Body Water; Cystic Fibrosis; Disease Models, Animal; Fluid Therapy; Mannitol; Mice; Mucociliary Clearance; Sodium Chloride	2001
Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients. Journal of pediatric gastroenterology and nutrition, 2001, Volume: 33, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Infective Agents; Biomarkers; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Inflammation; Intestinal Mucosa; Intestines; Lactulose; Lansoprazole; Longitudinal Studies; Male; Mannitol; Nitric Oxide; Omeprazole; Permeability; Rhamnose	2001
Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells. American journal of respiratory cell and molecular biology, 2001, Volume: 25, Issue:6 Topics: Bacterial Capsules; Cystic Fibrosis; Dose-Response Relationship, Drug; Glycosaminoglycans; Humans; Lipopolysaccharides; Mannitol; Mannose; Monocytes; Osmolar Concentration; Phagocytosis; Pneumonia, Bacterial; Proteolipids; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Saline Solution, Hypertonic; Sodium Chloride; Temperature	2001
Small intestinal permeability and orocaecal transit time in cystic fibrosis. Archives of disease in childhood, 1990, Volume: 65, Issue:6 Topics: Adolescent; Breath Tests; Cellobiose; Child; Child, Preschool; Cystic Fibrosis; Female; Gastrointestinal Transit; Humans; Intestinal Absorption; Intestine, Small; Lactulose; Male; Mannitol	1990
Active and passive sugar absorption in pancreatic insufficiency. Journal of pediatric gastroenterology and nutrition, 1989, Volume: 8, Issue:2 Topics: 3-O-Methylglucose; Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cystic Fibrosis; Dietary Carbohydrates; Exocrine Pancreatic Insufficiency; Female; Humans; Intestinal Absorption; Lactulose; Male; Mannitol; Methylglucosides; Pancreatitis	1989
Abnormal jejunal potential difference in cystic fibrosis. Lancet (London, England), 1989, Mar-04, Volume: 1, Issue:8636 Topics: Action Potentials; Adolescent; Adult; Cystic Fibrosis; Dinoprostone; Female; Glucose; Humans; Jejunum; Male; Mannitol; Muscle Contraction; Pilocarpine; Sodium Chloride	1989
Renal function in patients with cystic fibrosis. The Journal of pediatrics, 1971, Volume: 79, Issue:1 Topics: Adolescent; Child; Cystic Fibrosis; Diuresis; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Concentrating Ability; Kidney Function Tests; Male; Mannitol; Natriuresis; Sodium; Sodium Chloride; Vasopressins; Water; Water-Electrolyte Balance	1971